MENUNews Archive
Date: 08/17/2020
Researchers at the University of Michigan have discovered a new potential treatment approach for DIPG. One that significantly lengthened survival times in two mouse models.
Date: 08/07/2020
Research led by the Rogel Cancer Center is trying a new approach: Make radiation therapy more effective for glioblastoma patients by targeting a critical metabolic pathway and disrupting its ability to repair the DNA damage caused by the radiation.
Date: 07/28/2020
The Rogel Cancer Center continued to be among the nation’s best cancer programs and the only one in Michigan to be rated.
Date: 07/22/2020
New data on outcomes of people with cancer diagnosed with COVID-19 show a racial disparity in access to Remdesivir, an antiviral drug that shortens hospital stays, and increases mortality associated with dexamethasone.
Date: 07/09/2020
A University of Michigan-led study is shedding new light on the way pancreatic cancer cells turn nearby connective tissue cells into co-conspirators in their deadly growth. The findings also suggest a new potential strategy against pancreatic cancer by identifying critical components of metabolic cross talk between cells that might be attacked with new therapies, starving the cancer cells of vital nutrients.
Katz awarded $1.4M from American Cancer Society to examine disparities in genetic testing for cancer
Date: 07/06/2020
A $1.4 million grant from the American Cancer Society will allow a team of researchers led by the University of Michigan Rogel Cancer Center to survey a diverse group of breast cancer patients and their relatives about their experience with genetic testing and their understanding of hereditary cancer risk and prevention.
Date: 06/29/2020
A microRNA that is normally involved in immune cell differentiation helps to initiate and drive the development of the most prevalent and deadly form of ovarian cancer, research led by the University of Michigan Rogel Cancer Center and Case Western Reserve University has found.
Date: 06/27/2020
Research has proved the HPV vaccine is effective, but vaccinations should also be coupled with preventive cervical cancer screening.
Date: 06/25/2020
A team of researchers at the University of Michigan Rogel Cancer has been awarded $4 million from the National Cancer Institute as part of its Cancer Moonshot program. The grant will fund efforts to increase rates of genetic testing among cancer patients who have family histories concerning for hereditary cancer syndromes.
Date: 06/24/2020
Dana Dolinoy, Ph.D., received a $6.9 million R35 award from the National Institute of Environmental Health Sciences. The award is granted from the NIEHS Revolutionizing Innovative, Visionary Environmental Health Research (RIVER) program.